Literature DB >> 12440232

Systemic lupus erythematosus among Arabs.

George S Habib1, Walid R Saliba.   

Abstract

BACKGROUND: The prevalence of clinical manifestations and laboratory parameters in systemic lupus erythematosus differ among various ethnic groups. Few studies have reported on SLE in Arabs.
OBJECTIVES: To summarize the demographic, clinical and laboratory features of Arab SLE patients and to compare them with other series from different Arab countries.
METHODS: We reviewed the charts of all Arab SLE patients who had been seen at the Carmel Medical Center in Halfa, the Nazareth Hospital and the Holy Family Hospital in Nazareth, and a professional clinic (a referral outpatient clinic of the largest health maintenance organization in Israel) in Acre--all cities in northern Israel. Only patients with symptoms of more than one year were included. Demographic, clinical and laboratory parameters were documented and compared with those of four series from different Arab countries.
RESULTS: The study group comprised 34 patients. The majority of the patients was Moslem; there were a few Druze and one Christian. There was no statistical difference between our patients and any of the other Arab series in terms of arthritis, neuropsychiatric manifestations and VDRL. The presence of serositis and mucocutaneous manifestations was significantly lower in our series compared to some of the other series. However, there was significantly less renal involvement in our patients compared to each of the other series.
CONCLUSIONS: The prevalence of most clinical and laboratory parameters in Israeli Arab SLE patients is comparable to that of other series of SLE patients from different Arab countries. The prevalence of renal involvement in Israeli Arab SLE patients seems to be lower than in SLE patients from different Arab countries.

Entities:  

Mesh:

Year:  2002        PMID: 12440232

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  6 in total

1.  Incidence and prevalence of systemic lupus erythematosus among Arab and Chaldean Americans in southeastern Michigan: the Michigan Lupus Epidemiology and Surveillance Program.

Authors:  Michelle Housey; Peter DeGuire; Sarah Lyon-Callo; Lu Wang; Wendy Marder; W Joseph McCune; Charles G Helmick; Caroline Gordon; J Patricia Dhar; James Leisen; Emily C Somers
Journal:  Am J Public Health       Date:  2015-03-19       Impact factor: 9.308

2.  Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt.

Authors:  Ashraf Bakr
Journal:  Pediatr Nephrol       Date:  2005-06-07       Impact factor: 3.714

3.  Is familial lupus different from sporadic lupus? Data from LUMINA (LXXIII), a multiethnic US cohort.

Authors:  P I Burgos; G McGwin; J D Reveille; L M Vilá; E E Brown; G S Alarcon
Journal:  Lupus       Date:  2010-08-09       Impact factor: 2.911

4.  Relationship between hyperuricemia and serositis in patients with lupus nephritis.

Authors:  Ping Nie; Liangqian Hu; Bing Li; Yan Lou; Manyu Luo; Yali Wang; Xuehong Lu; Ping Luo
Journal:  Int Urol Nephrol       Date:  2021-05-10       Impact factor: 2.370

5.  Sudanese and Swedish patients with systemic lupus erythematosus: immunological and clinical comparisons.

Authors:  Sahwa Elbagir; Amir I Elshafie; Elnour M Elagib; NasrEldeen A Mohammed; Mawahib I E Aledrissy; Azita Sohrabian; Musa A M Nur; Elisabet Svenungsson; Iva Gunnarsson; Johan Rönnelid
Journal:  Rheumatology (Oxford)       Date:  2020-05-01       Impact factor: 7.580

6.  Correlation of plasma and urine Wnt5A with the disease activity and cutaneous lesion severity in patients with systemic lupus erythematosus.

Authors:  Shuhong Chi; Jing Xue; Xiaodong Chen; Xiaoming Liu; Yanhong Ji
Journal:  Immunol Res       Date:  2021-12-03       Impact factor: 2.829

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.